Subject: Update and increase in production of COVID-19 PCR tests
From: "Demirci, Hasan" <[email-masked]>
To: Tamar Gabunia <[email-masked]>
Cc: Ayhan Isler {Sale~Ankara Dia} <[email-masked]>, Anzor tchavtchavadze <[email-masked]>, Maia Nikoleishvili <[email-masked]>, Tinatin Khardziani <[email-masked]>, "Kanybekova, Zhanar" <[email-masked]>, Arsenat Toishybayev <[email-masked]>
Date: Mon, 29 Mar 2021 12:01:24 +0000

Dear Ms. Gabunia,

I hope this email finds you well and COVID is now much better manageable in Georgia.

It has been a while and I wanted to update you regarding our supply in instruments and reagents. We have installed both cobas 6800's and everything is running as planned. We have assigned our colleagues both from Kazakhstan and Russia to make a smooth installation and training in time.

In the mean time, our global colleagues have improved the processes and with additional investments a significant increase has been achieved in reagents manufacturing. I gladly inform you that in a couple of months we will be able to provide with higher test amounts for Georgia, up to 13,000 tests per week. This can bring a significant efficiency by consolidating more tests on fewer instruments.

I hope spring and summer bring better days ahead with new diagnosis, prevention and treatment options. We are always in your disposal to support you in managing the pandemic.

Kind regards.

Hasan Demirci

Head of
Central Asia and Caucasian Countries

Roche Diagnostics

Roche Kazakhstan LLP

137, Luganskiy Street, Medeuskiy District

Almaty, 050051

Kazakhstan

Tel

: +
7 (727) 321 24 24

Mobile

: +7 (701) 351 91 69

________________________________________________________
Confidentiality Note:  This message is intended only for the use of the named recipients and may contain confidential and/or privileged information.  If you are not the intended recipient, please contact the sender and delete this message. Any unauthorized use of the information contained in this message is prohibited.